Graft-versus-host Disease
📧 Sign up to get email alerts when something new happens for Graft-versus-host Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Myfortic - Treatment for Extensive cGvHD [Phase 3]
Phase 3 trial of Myfortic for extensive chronic graft-versus-host disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Trial update examining whether adnexal involvement affects the severity and prognosis of chronic graft-versus-host disease (cGVHD) based on …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Recombinant Human Keratinocyte Growth Factor in Unrelated and Related Transplants [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating recombinant human keratinocyte growth factor in unrelated and related transplants for graft-versus-host …
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Keratinocyte Growth Factor to Prevent Acute GVHD [Phase 1, Phase 2]
A Phase 1/2 trial evaluated keratinocyte growth factor (palifermin) for prevention of acute graft-versus-host disease and has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant [NA]
A completed clinical trial evaluated Thymoglobulin to prevent acute graft-versus-host disease in patients with acute myeloid leukemia or acu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: Alemtuzumab Use (MabCampath®) in Hematopoietic Transplant of Unrelated Donor With Reduced Intensity Conditioning [Phase 2]
Phase 2 study of alemtuzumab (MabCampath) in hematopoietic transplantation from an unrelated donor with reduced intensity conditioning was t…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease [Phase 2]
Phase 2 trial evaluating daily interleukin-2 for steroid-refractory chronic graft-versus-host disease; results were posted on 2015-01-15.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol [NA]
The University of Wisconsin's hMSC bone marrow donor protocol trial (NCT01463475) has completed, involving graft-versus-host disease and acu…
-
CLINICAL_TRIALS trial_result · 2014-11-14Clinical Trial Update: Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells [Phase 3]
A Phase 3 trial is investigating mesenchymal stromal cells for chronic graft-versus-host disease. The current status of the trial is unknown…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Treatment of Steroid Resistant GVHD by Infusion MSC [Phase 1, Phase 2]
An update on a Phase 1/2 trial evaluating infusion of mesenchymal stem cells to treat steroid-resistant graft-versus-host disease, which has…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating a sirolimus, mycophenolate mofetil, and bortezomib regimen as graft-versus-host disease prophylaxis after reduced…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease [Phase 3]
A Phase 3 trial evaluating low-dose prednisone or methylprednisolone for newly diagnosed acute graft-versus-host disease, with results poste…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating addition of etanercept and extracorporeal photopheresis to standard graft-versus-host disease prophylaxis …
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation [Phase 2]
Phase 2 trial evaluating palifermin to reduce acute graft-versus-host disease in patients with hematologic malignancies undergoing allogenei…
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]
Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…
-
CLINICAL_TRIALS trial_result · 2014-08-12Clinical Trial Update: Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer [Phase 2]
This Phase 2 trial tested sirolimus, tacrolimus, and antithymocyte globulin for preventing graft-versus-host disease in patients undergoing …
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease [Phase 3]
A Phase 3 trial evaluated etanercept (Enbrel) as the sole treatment for Grade I acute graft-versus-host disease, with results posted in 2014…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans [NA]
A clinical trial evaluating azithromycin-based therapy for bronchiolitis obliterans and graft-versus-host disease was terminated.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation [Phase 2]
A Phase 2 trial evaluating visilizumab to prevent graft-versus-host disease after allogeneic hematopoietic cell transplantation was terminat…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
A Phase 2 clinical trial assessed etanercept for preventing complications following hematopoietic stem cell transplantation, with results po…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease [Phase 1]
Phase 1 trial evaluating everolimus combined with cyclosporine A and prednisolone for graft-versus-host disease; the study status is termina…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation [Phase 2]
Phase 2 trial update reporting results on prophylaxis for acute graft-versus-host disease after allogeneic peripheral blood hematopoietic ce…
-
CLINICAL_TRIALS trial_result · 2014-04-17Clinical Trial Update: Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 3]
Phase 3 trial update evaluating laboratory-treated donor bone marrow in patients undergoing donor stem cell transplant for hematologic cance…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant [Phase 1, Phase 2]
This clinical trial update summarizes completed Phase 1/2 results evaluating vorinostat to prevent graft-versus-host disease after reduced-i…
-
CLINICAL_TRIALS trial_result · 2014-04-08Clinical Trial Update: Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating tacrolimus and sirolimus as graft-versus-host disease prophylaxis after allogeneic non-myeloablative peripheral blo…